Clinico-laboratory profile of Kawasaki disease with arthritis in children
Kawasaki disease (KD) is associated with several musculoskeletal manifestations. Although arthritis has been reported to occur in 2.3-31% of children with KD, there is paucity of detailed studies on the subject. We report our experience on arthritis in children with KD. Data were collated from a review of records of patients diagnosed with KD and arthritis during the period January 1994-June 2019. Eight hundred sixty-five children (male:female 29:11) were diagnosed with KD during this period-of these, 40 (4.6%) had arthritis. Median day of diagnosis of KD was 17 days. Twenty-nine (72.5%), 8 (20%), and 3 (8.6%) children developed arthritis in acute, subacute, and convalescent phases of KD, respectively. Oligoarticular involvement was observed in 32 (80%) children and among these, 7 (20%) had monoarthritis. Predominant joints involved were knee (74.3%), ankle (40%), and hip (28.6%). Thirty-two children (80%) were treated with non-steroidal anti-inflammatory drugs (NSAIDs). Median duration of arthritis was 10 days (range, 2-180 days) with uneventful recovery in all cases. Three (7.5%) children had coronary artery ectasia which regressed on follow-up.Conclusion: Arthritis in KD is usually non-erosive, self-limiting, and responds well to a short course of NSAIDs.What is Known:• Arthritis has been reported to occur in 2.3-31% of children with KD.• Arthritis in KD is usually oligoarticular, non-erosive, and responds well to short course of non-steroidal anti-inflammatory drugs.What is New:• Children with KD and arthritis do not appear to be at increased risk of development of coronary artery abnormalities.• Arthritis in children with KD can result in diagnostic confusion, and diagnosis of KD may get delayed.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:179 |
---|---|
Enthalten in: |
European journal of pediatrics - 179(2020), 6 vom: 23. Juni, Seite 875-879 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Guleria, Sandesh [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Inflammatory Agents, Non-Steroidal |
---|
Anmerkungen: |
Date Completed 02.03.2021 Date Revised 02.03.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00431-020-03582-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM305718010 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM305718010 | ||
003 | DE-627 | ||
005 | 20231225121807.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00431-020-03582-y |2 doi | |
028 | 5 | 2 | |a pubmed24n1019.xml |
035 | |a (DE-627)NLM305718010 | ||
035 | |a (NLM)31974671 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Guleria, Sandesh |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinico-laboratory profile of Kawasaki disease with arthritis in children |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.03.2021 | ||
500 | |a Date Revised 02.03.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Kawasaki disease (KD) is associated with several musculoskeletal manifestations. Although arthritis has been reported to occur in 2.3-31% of children with KD, there is paucity of detailed studies on the subject. We report our experience on arthritis in children with KD. Data were collated from a review of records of patients diagnosed with KD and arthritis during the period January 1994-June 2019. Eight hundred sixty-five children (male:female 29:11) were diagnosed with KD during this period-of these, 40 (4.6%) had arthritis. Median day of diagnosis of KD was 17 days. Twenty-nine (72.5%), 8 (20%), and 3 (8.6%) children developed arthritis in acute, subacute, and convalescent phases of KD, respectively. Oligoarticular involvement was observed in 32 (80%) children and among these, 7 (20%) had monoarthritis. Predominant joints involved were knee (74.3%), ankle (40%), and hip (28.6%). Thirty-two children (80%) were treated with non-steroidal anti-inflammatory drugs (NSAIDs). Median duration of arthritis was 10 days (range, 2-180 days) with uneventful recovery in all cases. Three (7.5%) children had coronary artery ectasia which regressed on follow-up.Conclusion: Arthritis in KD is usually non-erosive, self-limiting, and responds well to a short course of NSAIDs.What is Known:• Arthritis has been reported to occur in 2.3-31% of children with KD.• Arthritis in KD is usually oligoarticular, non-erosive, and responds well to short course of non-steroidal anti-inflammatory drugs.What is New:• Children with KD and arthritis do not appear to be at increased risk of development of coronary artery abnormalities.• Arthritis in children with KD can result in diagnostic confusion, and diagnosis of KD may get delayed | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Arthritis | |
650 | 4 | |a Children | |
650 | 4 | |a Coronary artery abnormalities | |
650 | 4 | |a Echocardiography | |
650 | 4 | |a Kawasaki disease | |
650 | 4 | |a Musculoskeletal involvement | |
650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
700 | 1 | |a Pilania, Rakesh Kumar |e verfasserin |4 aut | |
700 | 1 | |a Jindal, Ankur Kumar |e verfasserin |4 aut | |
700 | 1 | |a Singh, Ankita |e verfasserin |4 aut | |
700 | 1 | |a Vignesh, Pandiarajan |e verfasserin |4 aut | |
700 | 1 | |a Suri, Deepti |e verfasserin |4 aut | |
700 | 1 | |a Rawat, Amit |e verfasserin |4 aut | |
700 | 1 | |a Gupta, Anju |e verfasserin |4 aut | |
700 | 1 | |a Singh, Surjit |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of pediatrics |d 1978 |g 179(2020), 6 vom: 23. Juni, Seite 875-879 |w (DE-627)NLM000029718 |x 0340-6199 |7 nnns |
773 | 1 | 8 | |g volume:179 |g year:2020 |g number:6 |g day:23 |g month:06 |g pages:875-879 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00431-020-03582-y |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 179 |j 2020 |e 6 |b 23 |c 06 |h 875-879 |